Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users

K Brill, T Norpoth, J Schnitker, M Albring - Contraception, 1991 - Elsevier
Efficacy, cycle control, tolerance, and adverse events were studied in a clinical Phase IV
study using a new progestogen, gestodene, in an amount of 75 μg combined with 30 μg …
被引用次数：63 相关文章

Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users

K Brill, T Norpoth, J Schnitker, M Albring - Contraception, 1991 - pubmed.ncbi.nlm.nih.gov
Efficacy, cycle control, tolerance, and adverse events were studied in a clinical Phase IV
study using a new progestogen, gestodene, in an amount of 75 micrograms combined with …

[引用][C] Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users

K BRILL, T NORPOTH, J SCHNITKER… - Contraception …, 1991 - pascal-francis.inist.fr
Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …

Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users.

K Brill, T Norpoth, J Schnitker, M Albring - Contraception, 1991 - europepmc.org
Efficacy, cycle control, tolerance, and adverse events were studied in a clinical Phase IV
study using a new progestogen, gestodene, in an amount of 75 micrograms combined with …

Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users

K Brill, T Norpoth, J Schnitker, M Albring - Contraception, 1991 - hero.epa.gov
Efficacy, cycle control, tolerance, and adverse events were studied in a clinical Phase IV
study using a new progestogen, gestodene, in an amount of 75 micrograms combined with …

Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users

K Brill, T Norpoth, J Schnitker, M Albring - Contraception, 1991 - contraceptionjournal.org
Efficacy, cycle control, tolerance, and adverse events were studied in a clinical Phase IV
study using a new progestogen, gestodene, in an amount of 75 μg combined with 30 μg …

[引用][C] CLINICAL EXPERIENCE WITH A MODERN LOW-DOSE ORAL CONTRACEPTIVE IN ALMOST 100,000 USERS

K BRILL, T NORPOTH, J SCHNITKER, M ALBRING - Contraception, 1991 - Elsevier